161 related articles for article (PubMed ID: 15884112)
1. Effects of mycophenolate mofetil vs cyclosporine administration on graft survival and function after islet allotransplantation in diabetic rats.
Fotiadis C; Xekouki P; Papalois AE; Antonakis PT; Sfiniadakis I; Flogeras D; Karampela E; Zografos G
World J Gastroenterol; 2005 May; 11(18):2733-8. PubMed ID: 15884112
[TBL] [Abstract][Full Text] [Related]
2. Steroid-free maintenance of islet allografts using mycophenolate mofetil and cyclosporine in the non-human primate.
Buss J; Essig E; Osei K; Brodsky S; Hadley G; Rajab A
Ann Transplant; 2011; 16(2):88-97. PubMed ID: 21716191
[TBL] [Abstract][Full Text] [Related]
3. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Wennberg L; Song Z; Bennet W; Zhang J; Nava S; Sundberg B; Bari S; Groth CG; Korsgren O
Transplantation; 2001 Apr; 71(8):1024-33. PubMed ID: 11374396
[TBL] [Abstract][Full Text] [Related]
4. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression.
du Toit D; Muller C; Page B; Louw J
Microsc Res Tech; 1998 Nov; 43(4):347-55. PubMed ID: 9849976
[TBL] [Abstract][Full Text] [Related]
5. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
6. [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].
Huang H; Zheng W; Lin M; Fu J; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):191-3. PubMed ID: 12133455
[TBL] [Abstract][Full Text] [Related]
7. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of allograft survival in diabetic rats treated with cyclosporine by deoxyguanosine pretreatment of pancreatic islets of Langerhans.
al-Abdullah IH; Kumar AM; al-Adnani MS; Abouna GM
Transplantation; 1991 May; 51(5):967-71. PubMed ID: 2031280
[TBL] [Abstract][Full Text] [Related]
9. Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats.
Balamurugan AN; Nelson EJ; Ramakrishna B; Gunasekaran S
Xenotransplantation; 2007 Jul; 14(4):316-22. PubMed ID: 17669173
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
11. Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival.
Kahu J; Lõhmus A; Ilmoja M; Kirsimägi U; Timberg G; Peetsalu A
Medicina (Kaunas); 2007; 43(12):953-8. PubMed ID: 18182839
[TBL] [Abstract][Full Text] [Related]
12. In vivo test of two low doses of mycophenolate mofetil in an experimental model of islet allotransplantation.
Xekouki P; Papalois A; Fotiadis C; Sfiniadakis J; Karampela E; Papadopoulou A; Grigoriou T; Sechas MN
Transplant Proc; 2002 Aug; 34(5):1446-8. PubMed ID: 12176433
[No Abstract] [Full Text] [Related]
13. Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft.
Bogossian H; Frommeyer G; Ninios I; Bandorski D; Seyfarth M; Matzaroglou C; Lemke B; Eckardt L; Zarse M; Kafchitsas K
Cardiovasc Ther; 2016 Aug; 34(4):183-90. PubMed ID: 26924260
[TBL] [Abstract][Full Text] [Related]
14. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
15. Synergism of a natural plant product, oleanolic acid with calcineurin inhibitor in prolonging islet allograft survival.
Angaswamy N; Tiriveedhi V; Banan B; Benshoff N; Chapman W; Mohanakumar T
Transpl Immunol; 2013 Dec; 29(1-4):64-70. PubMed ID: 24036218
[TBL] [Abstract][Full Text] [Related]
16. The effect of combination therapy with cyclosporine A and hydrocortisone on glucose metabolism in diabetic rats following pancreatic islet transplantation.
Saudek F; Kazdová L; Nozicková M; Vrána A; Cíhalová E; Ruzbarský V
Physiol Res; 1995; 44(2):79-86. PubMed ID: 8789318
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.
Birnbaum F; Böhringer D; Sokolovska Y; Sundmacher R; Reinhard T
Transplantation; 2005 Apr; 79(8):964-8. PubMed ID: 15849551
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats.
Merani S; Pawlick RL; Edgar RL; Toso C; Emamaullee J; Anderson CC; Shapiro AM
Transplantation; 2009 Jan; 87(1):59-65. PubMed ID: 19136892
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.
Du CY; Xu EK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
